Amyris

Amyris Biotechnologies creates renewable products that focus on fuels and chemicals that provide no-compromise sustainable alternatives to a broad range of petroleum-sourced products. It uses an industrial synthetic biology platform that applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. Its technology creates products that support biopharmaceutical drug discovery and production, from cosmetic emollients and fragrances to fuels, solvents, lubricants, and nutraceuticals.

Amyris headquartered in United States, North America, operates in the Biotechnology, CleanTech, Chemical, Renewable Energy sector. The company focuses on Biotechnology and has secured $778.1B in funding across 416 round(s). With a team of 1001-5000 employees, Amyris is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Amyris, raised $41.8M. Discover more about their projects, partnerships, and impact on our platform.